Rocket Pharmaceuticals' strategic realignment initiative in July pulled funding from fanca-cel, which the biotech was ...
Since 1990, the mortality rate for children born with Down syndrome and a congenital heart defect has more than halved. This has been shown by a study by the University of Gothenburg. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback